Coloplast A/S (OTCMKTS:CLPBY) Reaches New 1-Year Low – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares hit a new 52-week low on Monday . The company traded as low as $5.86 and last traded at $5.93, with a volume of 3026 shares trading hands. The stock had previously closed at $6.00.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CLPBY. The Goldman Sachs Group lowered shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Coloplast A/S has a consensus rating of “Hold”.

Coloplast A/S Price Performance

The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30. The firm has a market cap of $13.75 billion, a price-to-earnings ratio of 43.57, a price-to-earnings-growth ratio of 1.87 and a beta of 0.18. The company’s fifty day moving average is $6.43 and its two-hundred day moving average is $7.55.

Coloplast A/S (OTCMKTS:CLPBY) last posted its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 31.96%. The business had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.11 billion. Equities research analysts forecast that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.